Resistance to Checkpoint Blockade Therapy Through Inactivation of Antigen Presentation
Demographics (1)
- Age - Subject's age (phv00352929.v1.p1)
Disease Events (4)
- AFFECTION_STATUS - Affection status (Melanoma) (phv00352922.v1.p1)
- HISTOLOGICAL_TYPE - Sample histology (phv00352934.v2.p1)
- TUMOR_GRADE - Tumor grade of sample (phv00352938.v2.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00352937.v2.p1)
Other (16)
- ANALYTE_TYPE - Analyte type (phv00352932.v2.p1)
- BODY_SITE - Location from where sample was obtained (phv00352931.v2.p1)
- CONSENT - Consent group for data-sharing (phv00352921.v1.p1)
- Ethnicity - Subject's ethnicity/heritage (phv00352928.v1.p1)
- Gender - Subject's gender (phv00352927.v1.p1)
- IS_TUMOR - Sample represents a tumor sample or not (phv00352933.v2.p1)
- PRIMARY_METASTATIC_TUMOR - Sample taken from metastatic tumor (phv00352935.v2.p1)
- PRIMARY_TUMOR_LOCATION - Sample taken from primary tumor (phv00352936.v2.p1)
- PUBLICATION_ID - SAMPLE_ID used in publication (Liu, D et al.) (phv00481424.v1.p1)
- SAMPLE_ID - Sample ID (phv00352930.v2.p1)
- SAMPLE_ID - Sample ID (phv00352924.v2.p1)
- SEQUENCING_CENTER - Sequencing center (phv00352940.v2.p1)
- SUBJECT_ID - Subject ID (phv00352926.v1.p1)
- SUBJECT_ID - Subject ID (phv00352920.v1.p1)
- SUBJECT_ID - Subject ID (phv00352923.v2.p1)
- TUMOR_TREATMENT - Tumor treatment (phv00352939.v2.p1)